Why considered
Source of the alkaloid dehydrocorybulbine (DHCB), identified in screening of traditional Chinese medicines as a strong non-opioid analgesic for both inflammatory and neuropathic pain in animal models.
How it may help neuropathic pain
DHCB reduces nerve-injury pain, acts at dopamine D2 and related targets, and modulates spinal pain pathways without classic opioid tolerance in rodent models of neuropathic pain.
Best-fit use case (conceptual)
Severe neuropathic pain where a non-opioid central analgesic is needed, especially when inflammatory and neuropathic components coexist. Evidence is preclinical; human neuropathy trials are still lacking.